- Zacks•7 hours ago
Merck & Co., Inc. (MRK) announced that the FDA has approved its pipeline candidate Zinplava (bezlotoxumab) for the prevention of Clostridium difficile recurrence.
- 24/7 Wall St.•yesterday
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||81.99 x 500|
|Ask||82.14 x 200|
|Day's Range||81.44 - 82.89|
|52wk Range||62.12 - 118.48|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-24.99|
|Avg Vol (3m)||1,502,650|
|Dividend & Yield||N/A (N/A)|